Article by Emily Gray Brosious, Extract
As Americans face an unprecedented national epidemic of opioid-related overdose deaths, efforts to utilize cannabis as a nontoxic alternative painkiller have been steadily gaining traction.
Now HelloMD, a major digital healthcare platform for medical cannabis patients, is teaming up with researchers at the University of California, Berkeley, to gather comprehensive data on the effects of cannabis on patients’ use of opioids.
HelloMD announced Tuesday, Sept. 20, the launch of “the largest patient survey concerning pain, opioid use and cannabis ever performed.”
“Opioid use and overdose statistics are staggering and should bring pause to every American,” Dr. Perry Solomon, Chief Medical Officer of HelloMD, said in a press release. “In partnering with the University of Berkeley, along with other esteemed colleagues, we hope to better understand how and why these dependencies are coming to be and how cannabis may affect the patient’s use of opioids, among many other findings needed to help curb this epidemic.”
The digital healthcare platform plans to survey 100,000 of its registered participants about how cannabis has affected their use of opioid painkillers. The survey will follow up on HelloMD’s January 2016 survey of 17,000 patients.